| Ident. | Authors (with country if any) | Title |
|---|
| 000001 (2017-01-10) |
Daniel Ysselstein [Danemark] ; Benjamin Dehay [France] ; Isabel M. Costantino [États-Unis] ; Matthew P. Frosch [États-Unis] ; Julia M. George [Royaume-Uni] ; Erwan Bezard [France] ; Jean-Christophe Rochet [Danemark] ; Georges Mccabe [États-Unis] | Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity. |
| 000035 (2017) |
Federico N. Soria [France] ; Olatz Pampliega [France] ; Mathieu Bourdenx [France] ; Wassilios G. Meissner [France] ; Erwan Bezard [France] ; Benjamin Dehay [France] | Exosomes, an Unmasked Culprit in Neurodegenerative Diseases |
| 000060 (2016-11) |
Anna Migdalska-Richards [Royaume-Uni] ; Liam Daly [Royaume-Uni] ; Erwan Bezard [France] ; Anthony H V. Schapira [Royaume-Uni] | Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice. |
| 000072 (2016-07-13) |
Wai Kin D. Ko [Royaume-Uni] ; Sandrine M. Camus [Royaume-Uni] ; Qin Li [Royaume-Uni] ; Yang Jianzhong [Royaume-Uni] ; Steve Mcguire [Royaume-Uni] ; Elsa Y. Pioli [Royaume-Uni] ; Erwan Bezard [Royaume-Uni] | An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models. |
| 000079 (2016-05-23) |
François Tison [France] ; Charlotte Keywood [Suisse] ; Mark Wakefield [France] ; Franck Durif [France] ; Jean-Christophe Corvol [France] ; Karla Eggert [France] ; Mark Lew [États-Unis] ; Stuart Isaacson [États-Unis] ; Erwan Bezard [France] ; Sonia-Maria Poli [Suisse] ; Christopher G. Goetz [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Olivier Rascol [France] | A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease. |
| 000091 (2016-02) |
Mathieu Bourdenx [France] ; Sandra Dovero [France] ; Philippe De Deurwaerdère [France] ; Qin Li [République populaire de Chine] ; Erwan Bezard [Royaume-Uni] | Early prenatal exposure to MPTP does not affect nigrostrial neurons in macaque monkey |
| 000093 (2016-01-21) |
Thibaud Thiollier [France] ; Caisheng Wu [République populaire de Chine] ; Hugues Contamin [France] ; Qin Li [Royaume-Uni] ; Jinlan Zhang [République populaire de Chine] ; Erwan Bezard [France] | Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson disease. |
| 000127 (2016) |
Sandra Dovero [France] ; Christian Gross [France] ; Erwan Bezard [France] | Unexpected toxicity of very low dose MPTP in mice: A clue to the etiology of Parkinson's disease? |
| 000148 (2016) |
Benjamin Dehay [France] ; Mickael Decressac [Italie] ; Mathieu Bourdenx [France] ; Irene Guadagnino [Italie] ; Pierre-Olivier Fernagut [France] ; Anna Tamburrino [Italie] ; Fares Bassil [France] ; Wassilios G. Meissner [France] ; Erwan Bezard [France] | Targeting α-synuclein: Therapeutic options. |
| 000165 (2016) |
Michel Engeln [France] ; Matthieu F. Bastide [France] ; Estelle Toulmé [France] ; Benjamin Dehay [France] ; Mathieu Bourdenx [France] ; Evelyne Doudnikoff [France] ; Qin Li [République populaire de Chine] ; Christian E. Gross [France] ; Eric Boué-Grabot [France] ; Antonio Pisani [Italie] ; Erwan Bezard [France] ; Pierre-Olivier Fernagut [France] | Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia. |
| 000199 (2016) |
Thibaud Thiollier [France] ; Caisheng Wu ; Hugues Contamin [France] ; Qin Li [Royaume-Uni] ; Jinlan Zhang ; Erwan Bezard [France] | Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease. |
| 000223 (2016) |
Mathieu Bourdenx [France] ; Jonathan Daniel [France] ; Emilie Genin [France] ; Federico N. Soria [France] ; Mireille Blanchard-Desce [France] ; Erwan Bezard [France] ; Benjamin Dehay [France] | Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases |
| 000227 (2016) |
Michel Engeln [France] ; Solène Ansquer [France] ; Emilie Dugast [France] ; Erwan Bezard [France] ; David Belin [Royaume-Uni] ; Pierre-Olivier Fernagut [France] | Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy. |
| 000271 (2016) |
Mathieu Schmitt [Belgique] ; Benjamin Dehay [France] ; Erwan Bezard [France] ; F Javier Garcia-Ladona [Belgique] | Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line. |
| 000275 (2016) |
Ludovico Arcuri [Italie] ; Riccardo Viaro [Italie] ; Simone Bido [Italie] ; Francesco Longo [Italie] ; Mariangela Calcagno [Italie] ; Pierre-Olivier Fernagut [France] ; Nurulain T. Zaveri [États-Unis] ; Girolamo Cal [Italie] ; Erwan Bezard [France] ; Michele Morari [Italie] | Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease. |
| 000354 (2016) |
Annalisa Pinna [Italie] ; Wai Kin D. Ko [Royaume-Uni] ; Giulia Costa [Italie] ; Elisabetta Tronci [Italie] ; Camino Fidalgo [Italie] ; Nicola Simola [Italie] ; Qin Li [Royaume-Uni] ; Mojgan Aghazadeh Tabrizi [Italie] ; Erwan Bezard [Royaume-Uni] ; Manolo Carta [Italie] ; Micaela Morelli [Italie] | Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease. |
| 000357 (2016) |
Wai Kin D. Ko [Royaume-Uni] ; Sandrine M. Camus [Royaume-Uni] ; Qin Li [Royaume-Uni] ; Jianzhong Yang [Royaume-Uni] ; Steve Mcguire [Royaume-Uni] ; Elsa Y. Pioli [Royaume-Uni] ; Erwan Bezard [France] | An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models. |
| 000359 (2016) |
Anna Migdalska-Richards [Royaume-Uni] ; Liam Daly [Royaume-Uni] ; Erwan Bezard [France] ; Anthony H V. Schapira [Royaume-Uni] | Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice. |
| 000361 (2016) |
Benjamin Dehay [France] ; Miquel Vila [Espagne] ; Erwan Bezard [France] ; Patrik Brundin [États-Unis] ; Jeffrey H. Kordower [États-Unis] | Alpha-synuclein propagation: New insights from animal models. |
| 000377 (2016) |
François Tison [France] ; Charlotte Keywood [Suisse] ; Mark Wakefield [Suisse] ; Franck Durif [France] ; Jean-Christophe Corvol [France] ; Karla Eggert [Allemagne] ; Mark Lew [États-Unis] ; Stuart Isaacson [États-Unis] ; Erwan Bezard [France] ; Sonia-Maria Poli [Suisse] ; Christopher G. Goetz [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Olivier Rascol [France] | A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease. |
| 000394 (2015-11-18) |
Weixing Shen [France] ; Joshua L. Plotkin [États-Unis] ; Veronica Francardo [Suède] ; Wai Kin D. Ko [France] ; Zhong Xie [République populaire de Chine] ; Qin Li [République populaire de Chine] ; Tim Fieblinger [Suède] ; Jürgen Wess [États-Unis] ; Richard R. Neubig [États-Unis] ; Craig W. Lindsley [États-Unis] ; P Jeffrey Conn [États-Unis] ; Paul Greengard [États-Unis] ; Erwan Bezard [France] ; M Angela Cenci [Suède] ; D James Surmeier [États-Unis] | M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia. |
